Bisphosphonates Induce Breast Cancer Cell Death In Vitro

• Published in: Journal of bone and mineral research 2000-11, Vol.15 (11), p.2211-2221
• Main Authors: Fromigue, Olivia, Lagneaux, Laurence, Body, Jean‐Jacques
• Format: Article
• Language: English
• Subjects: Amino Acid Chloromethyl Ketones - pharmacology; Annexins - metabolism; Antineoplastic agents; Antineoplastic Agents - pharmacology; apoptosis; Apoptosis - drug effects; Biological and medical sciences; bisphosphonates; bone metastases; breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Caspase Inhibitors; Caspases - metabolism; Cell Death - drug effects; Cell Nucleus - drug effects; Chemotherapy; Clodronic Acid - pharmacology; Cysteine Proteinase Inhibitors - pharmacology; Diphosphonates - pharmacology; Dose-Response Relationship, Drug; Female; Humans; Imidazoles - pharmacology; in vitro; Kinetics; Medical sciences; Pharmacology. Drug treatments; Tumor Cells, Cultured
• ISSN: 0884-0431; 1523-4681
• DOI: 10.1359/jbmr.2000.15.11.2211

Breast cancer frequently spreads to bone and is almost always associated with osteolysis. This tumor‐induced osteolysis is caused by increased osteoclastic bone resorption. Bisphosphonates are used successfully to inhibit bone resorption in tumor bone disease and may prevent development of new osteolytic lesions. The classical view is that bisphosphonates only act on bone cells. We investigated their effects on breast cancer cells using three human cell lines, namely, MCF‐7, T47D, and MDA.MB.231, and we tested four structurally different bisphosphonates: clodronate, pamidronate, ibandronate, and zoledronate. We performed time course studies for each bisphosphonate at various concentrations and found that all four compounds induced a nonreversible growth inhibition in both MCF‐7 and T47D cell lines in a time‐ and dose‐dependent manner. The MDA.MB.231 cell line was less responsive. Bisphosphonates induced apoptosis in MCF‐7 and cell necrosis in T47D cells. The inhibition of MCF‐7 cell proliferation could be reverted almost completely by the benzyloxycarbonyl‐Val‐Ala‐Asp(OMe)‐fluoromethyl ketone (z‐VAD‐fmk) inhibitor of caspases, suggesting that the apoptotic process observed in the MCF‐7 cell line is mediated, at least partly, by the caspase system. Caspase activity was little changed by bisphosphonates in T47D cells and the inhibitor of caspase did not modify bisphosphonates effects. In summary, we found that bisphosphonates inhibit breast cancer cell growth by inducing cell death in vitro. Such effects could contribute to the beneficial role of bisphosphonates in the treatment and the prevention of tumor‐induced osteolysis.